132 related articles for article (PubMed ID: 30578663)
1. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr
Burke AC; Telford DE; Edwards JY; Sutherland BG; Sawyez CG; Huff MW
Mol Nutr Food Res; 2019 Mar; 63(6):e1800833. PubMed ID: 30578663
[TBL] [Abstract][Full Text] [Related]
2. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
3. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr
Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Huff MW
Atherosclerosis; 2019 Jul; 286():60-70. PubMed ID: 31102954
[TBL] [Abstract][Full Text] [Related]
4. Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.
Ke JY; Cole RM; Hamad EM; Hsiao YH; Cotten BM; Powell KA; Belury MA
Mol Nutr Food Res; 2016 Feb; 60(2):313-24. PubMed ID: 26573879
[TBL] [Abstract][Full Text] [Related]
5. Leucine supplementation protects from insulin resistance by regulating adiposity levels.
Binder E; Bermúdez-Silva FJ; André C; Elie M; Romero-Zerbo SY; Leste-Lasserre T; Belluomo I; Duchampt A; Clark S; Aubert A; Mezzullo M; Fanelli F; Pagotto U; Layé S; Mithieux G; Cota D
PLoS One; 2013; 8(9):e74705. PubMed ID: 24086364
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
7. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW
Diabetes; 2009 Oct; 58(10):2198-210. PubMed ID: 19592617
[TBL] [Abstract][Full Text] [Related]
8. Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese
Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Drangova M; Huff MW
J Lipid Res; 2018 Sep; 59(9):1714-1728. PubMed ID: 30008441
[TBL] [Abstract][Full Text] [Related]
9. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.
Huong DT; Takahashi Y; Ide T
Nutrition; 2006 May; 22(5):546-52. PubMed ID: 16483743
[TBL] [Abstract][Full Text] [Related]
10. Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
Ke JY; Banh T; Hsiao YH; Cole RM; Straka SR; Yee LD; Belury MA
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28370954
[TBL] [Abstract][Full Text] [Related]
11. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats.
Cho KW; Kim YO; Andrade JE; Burgess JR; Kim YC
Eur J Nutr; 2011 Mar; 50(2):81-8. PubMed ID: 20567977
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.
Tsai VW; Zhang HP; Manandhar R; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Sainsbury A; Brown DA; Breit SN
Int J Obes (Lond); 2018 Mar; 42(3):561-571. PubMed ID: 29026214
[TBL] [Abstract][Full Text] [Related]
13. d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.
Han Y; Han HJ; Kim AH; Choi JY; Cho SJ; Park YB; Jung UJ; Choi MS
Mol Nutr Food Res; 2016 Jul; 60(7):1695-706. PubMed ID: 26920079
[TBL] [Abstract][Full Text] [Related]
14. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
15. Potential adverse effects of botanical supplementation in high-fat-fed female mice.
Fuller S; Yu Y; Mendoza T; Ribnicky DM; Cefalu WT; Floyd ZE
Biol Sex Differ; 2018 Sep; 9(1):41. PubMed ID: 30208938
[TBL] [Abstract][Full Text] [Related]
16. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
[TBL] [Abstract][Full Text] [Related]
17. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.
Upadhyay SK; Eckel-Mahan KL; Mirbolooki MR; Tjong I; Griffey SM; Schmunk G; Koehne A; Halbout B; Iadonato S; Pedersen B; Borrelli E; Wang PH; Mukherjee J; Sassone-Corsi P; Chandy KG
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2239-48. PubMed ID: 23729813
[TBL] [Abstract][Full Text] [Related]
18. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
19. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
Kwon EY; Choi MS
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
